Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABNB Airbnb	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.50 +1.7%	$100.00 ➝ $102.00	Underweight ➝ Underweight
ABT Abbott Laboratories	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$114.61 +1.1%	$130.00	Outperform
ABT Abbott Laboratories	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$114.61 +1.1%	$125.00 ➝ $130.00	Outperform ➝ Outperform
ACLX Arcellx	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.85 +6.3%	$109.00	Buy
ADI Analog Devices	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.40 +1.3%	$250.00 ➝ $250.00	Neutral ➝ Neutral
AFG American Financial Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.59 +0.4%	$132.00 ➝ $135.00	Market Perform ➝ Market Perform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AFRM Affirm	Upgraded by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Caintic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.15 +6.6%	$68.00	Neutral ➝ Buy
AGL agilon health	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.15	$7.00 ➝ $4.00	In-Line ➝ In-Line
AKBA Akebia Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.32	$7.50 ➝ $7.50	Buy ➝ Buy
ALB Albemarle	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Sison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.26 -4.0%	$100.00 ➝ $110.00	Equal Weight ➝ Equal Weight
ALGN Align Technology	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$234.06 -0.3%	$280.00 ➝ $270.00	Outperform ➝ Outperform
ALS Altius Minerals	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$25.25 -0.7%	C$24.00 ➝ C$26.00	Sector Perform
AMAT Applied Materials	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Muse Subscribe to MarketBeat All Access for the recommendation accuracy rating	$200.88 +0.4%	$250.00 ➝ $250.00	Overweight ➝ Overweight
AMP Ameriprise Financial	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$483.97 +0.7%	$490.00 ➝ $555.00	Buy ➝ Buy
ANET Arista Networks	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$400.15 +1.9%	$385.00 ➝ $460.00	Buy ➝ Buy
ANG Angling Direct	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 38 +7.0%	GBX 57	Buy
APOG Apogee Enterprises	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.76 -2.6%	$65.00 ➝ $75.00	Neutral ➝ Neutral
AQN Algonquin Power & Utilities	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.15	$6.00 ➝ $5.75	Neutral ➝ Neutral
AQST Aquestive Therapeutics	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.92 +1.4%	$9.00 ➝ $9.00	Market Outperform ➝ Market Outperform
ARMK Aramark	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.60 +0.9%	$40.00 ➝ $44.00	Buy ➝ Buy
ARWR Arrowhead Pharmaceuticals	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.02 -0.6%	$62.00 ➝ $62.00	Overweight ➝ Overweight
AVGO Broadcom	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Muse Subscribe to MarketBeat All Access for the recommendation accuracy rating	$180.73 +3.2%	$200.00 ➝ $225.00	Overweight ➝ Overweight
AVGO Broadcom	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$180.73 +3.2%	$204.00 ➝ $205.00	Buy ➝ Buy
AVNW Aviat Networks	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.84 -4.0%	$50.00 ➝ $50.00	Market Outperform ➝ Market Outperform
AVNW Aviat Networks	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.84 -4.0%	$51.00 ➝ $45.00	Buy ➝ Buy
AVNW Aviat Networks	Target Lowered by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.84 -4.0%	$40.00 ➝ $35.00	Outperform ➝ Outperform
AVTR Avantor	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.82 -0.7%	$30.00 ➝ $29.00	Buy ➝ Buy
AXP American Express	Downgraded by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Caintic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$269.00 -1.7%	$230.00	Neutral ➝ Sell
AXP American Express	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$269.00 -1.7%	$265.00 ➝ $270.00	Buy ➝ Hold
AXP American Express	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$269.00 -1.7%	$223.00 ➝ $250.00	Equal Weight ➝ Equal Weight
B Barnes Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.52 +0.1%	$38.00 ➝ $47.50	Hold ➝ Hold
BAP Credicorp	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$183.23 +0.4%	$143.00 ➝ $160.00	Sell ➝ Sell
BCAX Bicara Therapeutics	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.55 -7.8%	$47.00	Buy
BCAX Bicara Therapeutics	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.55 -7.8%		Buy
BCAX Bicara Therapeutics	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.55 -7.8%	$35.00	Overweight
BCAX Bicara Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.55 -7.8%		Overweight
BCS Barclays	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.14 +0.2%		Buy
BDTX Black Diamond Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.56 -2.7%	$16.00 ➝ $16.00	Outperform ➝ Outperform
BFAM Bright Horizons Family Solutions	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$136.53 +0.2%	$128.00 ➝ $145.00	Neutral ➝ Neutral
BFH Bread Financial	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.50 +0.4%	$37.00 ➝ $35.00	Underweight ➝ Underweight
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
BK Bank of New York Mellon	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.19 +1.0%	$73.00 ➝ $82.00	Buy ➝ Buy
BKNG Booking	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4,233.18 +1.5%	$3,900.00 ➝ $4,500.00	Overweight ➝ Overweight
BKNG Booking	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4,233.18 +1.5%	$3,976.00 ➝ $4,173.00	Equal Weight ➝ Equal Weight
BRK Brooks Macdonald Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,850 -0.5%		Hold
BSX Boston Scientific	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.83 +1.7%	$85.00 ➝ $95.00	Outperform ➝ Outperform
BTDR Bitdeer Technologies Group	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.07 +0.1%	$9.00 ➝ $9.00	Buy ➝ Buy
BTDR Bitdeer Technologies Group	Initiated by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.07 +0.1%	$14.00	Buy
BUD Anheuser-Busch InBev SA/NV	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.23 -1.2%	$68.00 ➝ $88.00	Buy ➝ Hold
BYIT Bytes Technology Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 506.50 -0.2%		House Stock
CBOE Cboe Global Markets	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$207.61 +0.1%	$210.00 ➝ $220.00	Overweight ➝ Overweight
CDE Coeur Mining	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.19 -0.2%	$7.00 ➝ $7.75	Buy ➝ Buy
CGON CG Oncology	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.82 -1.9%	$65.00 ➝ $65.00	Buy ➝ Buy
CION CION Investment	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.70 -0.6%	$13.00	Market Perform
CME CME Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$221.68 0.0%	$225.00 ➝ $240.00	Overweight ➝ Overweight
CME CME Group	Downgraded by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$221.68 0.0%	$244.00	Buy ➝ Neutral
CNQ Canadian Natural Resources	Target Raised by	Gerdes Energy Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$52.00 ➝ C$53.00
CNQ Canadian Natural Resources	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$56.00 ➝ C$58.00	Buy
CNQ Canadian Natural Resources	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$57.50 ➝ C$60.00	Outperform
CNQ Canadian Natural Resources	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$59.00 ➝ C$62.00	Outperform
CNQ Canadian Natural Resources	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$52.00 ➝ C$53.00	Sector Perform
CNQ Canadian Natural Resources	Upgraded by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$56.00 ➝ C$59.00	Hold ➝ Buy
CNQ Canadian Natural Resources	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.61 -0.4%	C$58.00 ➝ C$60.00	Outperform
CNQ Canadian Natural Resources	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Barth Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$49.61 -0.4%	C$48.00 ➝ C$51.00	Market Perform
CNR Canadian National Railway	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$154.96 +0.5%	C$176.00 ➝ C$169.00	Neutral
COF Capital One Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$149.47 -1.7%	$154.00 ➝ $158.00	Equal Weight ➝ Equal Weight
COOP Mr. Cooper Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.54 +1.3%	$103.00 ➝ $108.00	Overweight ➝ Overweight
COR Cencora	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$220.80 +0.6%	$270.00 ➝ $250.00	Outperform ➝ Outperform
CP Canadian Pacific Kansas City	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$110.01 -0.5%	C$136.00 ➝ C$137.00	Overweight
CRBG Corebridge Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.48 -1.2%	$33.00 ➝ $34.00	Equal Weight ➝ Equal Weight
CRWD CrowdStrike	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$293.01 +2.1%	$285.00	Neutral
CVS CVS Health	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$65.88 +1.0%	$62.00 ➝ $75.00	Outperform ➝ Outperform
CVX Chevron	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.76 -1.6%	$170.00 ➝ $170.00	Outperform ➝ Outperform
CVX Chevron	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.76 -1.6%	$189.00 ➝ $192.00	Buy ➝ Buy
CX CEMEX	Upgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.09 +3.6%	$9.00 ➝ $6.50	Underperform ➝ Sector Perform
DAL Delta Air Lines	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.64 +2.4%	$62.00 ➝ $65.00	Outperform ➝ Outperform
DDOG Datadog	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$123.72 +1.1%	$150.00	Outperform
DECK Deckers Outdoor	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$161.99 +2.0%	$204.17 ➝ $205.00	Buy
DOCS Doximity	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.32 +2.5%	$34.00 ➝ $45.00	In-Line ➝ In-Line
DT Dynatrace	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.26 -0.3%	$52.00	Neutral
DUOL Duolingo	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$284.95 +1.9%	$225.00 ➝ $355.00	Buy ➝ Buy
DXCM DexCom	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.43 +1.2%	$130.00 ➝ $120.00	Outperform ➝ Outperform
DY Dycom Industries	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$190.23 -0.3%	$200.00 ➝ $227.00	Overweight ➝ Overweight
EAT Brinker International	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$84.52 +2.5%	$69.00 ➝ $83.00	Neutral ➝ Neutral
EEFT Euronet Worldwide	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.03 0.0%	$136.00 ➝ $136.00	Buy ➝ Buy
EFX Equifax	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$286.34 +1.5%	$300.00 ➝ $315.00	Outperform ➝ Outperform
EFX Enerflex	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$8.79 -2.8%	C$11.00 ➝ C$12.00	Buy
EPAM EPAM Systems	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$195.18 +1.1%	$225.00 ➝ $225.00	Overweight ➝ Overweight
EQH Equitable	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.83 +0.2%	$59.00 ➝ $60.00	Overweight ➝ Overweight
ESI Ensign Energy Services	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.57 -1.5%	C$3.50 ➝ C$3.25	Buy
ESNT Essent Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.16 +0.6%	$64.00 ➝ $72.00	Overweight ➝ Overweight
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
ESTC Elastic	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.46 -0.9%		Hold
EVH Evolent Health	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.63 -1.0%	$42.00 ➝ $42.00	Outperform ➝ Outperform
EW Edwards Lifesciences	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.55 +6.2%	$85.00 ➝ $75.00	Outperform ➝ Outperform
EXPE Expedia Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$151.95 +0.6%	$130.00 ➝ $159.00	Equal Weight ➝ Equal Weight
FAF First American Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.86 +0.3%	$61.00 ➝ $70.00	Equal Weight ➝ Equal Weight
FBIN Fortune Brands Innovations	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.14 +0.4%	$86.00 ➝ $98.00	Buy ➝ Buy
FCX Freeport-McMoRan	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	O. Wowkodaw Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.59 -4.3%	$52.00 ➝ $53.00	Sector Perform ➝ Sector Perform
FG F&G Annuities & Life	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.36 -0.6%	$45.00 ➝ $44.00	Equal Weight ➝ Equal Weight
FICO Fair Isaac	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,988.00 +1.7%	$1,967.00 ➝ $2,109.00	Outperform ➝ Outperform
FM First Quantum Minerals	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$18.13 -3.5%	C$17.00 ➝ C$18.50	Sector Perform
FNF Fidelity National Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$60.16 +0.3%	$56.00 ➝ $59.00	Equal Weight ➝ Equal Weight
FOXA FOX	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.58 -0.1%	$43.00 ➝ $46.00	Buy ➝ Buy
FSLR First Solar	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$225.64 -1.7%	$343.00 ➝ $321.00	Buy ➝ Buy
FTRE Fortrea	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.67 +1.2%	$26.00 ➝ $23.00	Neutral ➝ Neutral
FTRE Fortrea	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.67 +1.2%	$22.00 ➝ $20.00	In-Line ➝ In-Line
FXNC First National	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.95 +3.2%	$22.00	Outperform
FYBR Frontier Communications Parent	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.35 +0.1%	$39.00 ➝ $38.50	Buy ➝ Hold
GFS GlobalFoundries	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Muse Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.53 -0.5%	$55.00 ➝ $40.00	Neutral ➝ Neutral
GKP Gulf Keystone Petroleum	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 133.30 +4.9%	GBX 190	Speculative Buy
GMAB Genmab A/S	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.59 +0.7%		Buy
GMED Globus Medical	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$70.06 +0.2%	$78.00 ➝ $80.00	Outperform ➝ Outperform
GNC Greencore Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 196 +8.8%		House Stock
GRPN Groupon	Reiterated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.27 -3.4%	$20.00 ➝ $20.00	Outperform ➝ Outperform
GS The Goldman Sachs Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$496.57 +0.4%	$550.00 ➝ $560.00	Buy ➝ Buy
GWRE Guidewire Software	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.58 +0.2%	$175.00 ➝ $204.00	Outperform ➝ Outperform
HAS Hasbro	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.11 -0.5%	$78.00 ➝ $82.00	Buy ➝ Buy
HBM Hudbay Minerals	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.26 -4.8%	C$14.50 ➝ C$15.00	Outperform
HCAT Health Catalyst	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.83 +2.8%	$8.00 ➝ $10.00	Outperform ➝ Outperform
HCI HCI Group	Target Lowered by	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.34 +2.0%	$130.00 ➝ $119.00	Buy ➝ Buy
HLI Houlihan Lokey	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$163.85 +1.9%	$170.00 ➝ $190.00	Buy ➝ Buy
HOLX Hologic	Target Lowered by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.26 +0.5%	$95.00 ➝ $90.00	Outperform ➝ Outperform
HOOD Robinhood Markets	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Moley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.61 +9.8%	$27.00 ➝ $27.00	Overweight ➝ Overweight
HSIC Henry Schein	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.99 +1.0%	$70.00 ➝ $74.00	In-Line ➝ In-Line
HUBS HubSpot	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$532.08 +1.9%	$600.00 ➝ $625.00	Buy ➝ Buy
HUM Humana	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$243.20 +2.9%	$400.00 ➝ $265.00	Outperform ➝ Outperform
HUM Humana	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$243.20 +2.9%	$308.00	Market Perform ➝ Outperform
HWM Howmet Aerospace	Initiated by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.99 +0.2%	$120.00	Positive
IBKR Interactive Brokers Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$147.59 -0.7%	$140.00 ➝ $163.00	Overweight ➝ Overweight
IBKR Interactive Brokers Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$147.59 -0.7%	$155.00 ➝ $170.00	Buy ➝ Buy
ICE Intercontinental Exchange	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$162.09 +1.6%	$170.00 ➝ $180.00	Overweight ➝ Overweight
ICLR ICON Public	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$287.56 -1.0%	$360.00 ➝ $350.00	Outperform ➝ Outperform
IMO Imperial Oil	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$105.31 -2.5%	C$94.00 ➝ C$97.00	Neutral
IOT Samsara	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.25 -1.1%	$46.00	Neutral
IPX Impax Asset Management Group	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 393 +5.1%	GBX 620 ➝ GBX 560	Buy
IQV IQVIA	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$226.78 +0.6%	$270.00 ➝ $265.00	Outperform ➝ Outperform
ISRG Intuitive Surgical	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$480.79 +2.0%	$515.00 ➝ $525.00	Outperform ➝ Outperform
IVN Ivanhoe Mines	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$19.13 -4.0%	C$21.00 ➝ C$22.00	Outperform
JELD JELD-WEN	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.78 -1.0%	$15.00 ➝ $17.00	Neutral ➝ Neutral
JNJ Johnson & Johnson	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$159.64 +0.1%	$175.00 ➝ $178.00	Outperform ➝ Outperform
JXN Jackson Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$97.31 +0.4%	$109.00 ➝ $111.00	Overweight ➝ Overweight
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
KBR KBR	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.34 +0.1%	$73.00 ➝ $75.00	Overweight ➝ Overweight
KLAC KLA	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$783.90 +0.3%	$925.00 ➝ $925.00	Neutral ➝ Neutral
KMB Kimberly-Clark	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.01 +0.9%	$146.00 ➝ $147.00	Hold ➝ Hold
KRON Kronos Bio	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.94 -5.1%	$6.00 ➝ $6.00	Overweight ➝ Overweight
LAZ Lazard	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.35 -0.3%	$49.00 ➝ $52.00	Neutral ➝ Neutral
LB LandBridge	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mackay Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.85 +0.1%	$38.00 ➝ $43.00	Buy ➝ Buy
LCID Lucid Group	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.44 +0.6%	$4.00 ➝ $4.00	Neutral ➝ Neutral
LEGN Legend Biotech	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.06 -3.1%	$86.00	Buy
LGN Logan Energy	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.81 -1.2%	C$1.75 ➝ C$1.50	Outperform
LIF Labrador Iron Ore Royalty	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.32 -0.5%	C$31.00 ➝ C$32.00	Sector Perform
LNC Lincoln National	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.39 +0.9%	$35.00 ➝ $36.00	Equal Weight ➝ Equal Weight
LNW Light & Wonder	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.04 +2.0%	$120.00	Buy
LPLA LPL Financial	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$238.71 -0.2%	$215.00 ➝ $250.00	Neutral ➝ Neutral
LYV Live Nation Entertainment	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$111.61 +0.7%	$125.00 ➝ $130.00	Outperform ➝ Outperform
MAU Montage Gold	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.01 +0.5%	C$2.60 ➝ C$2.20	Buy
MBX MBX Biosciences	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.85 -9.7%	$30.00	Overweight
MBX MBX Biosciences	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.85 -9.7%	$35.00	Buy
MBX MBX Biosciences	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.85 -9.7%	$40.00	Buy
MBX MBX Biosciences	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.85 -9.7%	$44.00	Buy
MC Moelis & Company	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.21 +0.9%	$54.00 ➝ $60.00	Sell ➝ Sell
MCD McDonald's	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$301.90 +0.3%		Hold ➝ Buy
MDT Medtronic	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$88.14 +1.3%	$92.00 ➝ $98.00	Sector Perform ➝ Sector Perform
MEC Mayville Engineering	Reiterated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.04 -0.4%	$30.00 ➝ $30.00	Outperform ➝ Outperform
MKTX MarketAxess	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$275.89 +0.8%	$235.00 ➝ $265.00	Neutral ➝ Neutral
MO Altria Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.55 -0.7%	$44.50 ➝ $48.00	Neutral ➝ Neutral
MORN Morningstar	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$335.28 +7.2%	$390.00	Buy
MOTR Motorpoint Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 160 +4.6%		House Stock
MRVI Maravai LifeSciences	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.68 -1.9%	$8.00 ➝ $7.00	Neutral ➝ Neutral
MS Morgan Stanley	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.51 -0.1%	$102.00 ➝ $112.00	Neutral ➝ Neutral
MSFT Microsoft	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$414.71 +1.3%	$600.00 ➝ $600.00	Buy ➝ Buy
MSFT Microsoft	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$414.71 +1.3%		Outperform ➝ Market Perform
MTCH Match Group	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.72 +0.5%	$38.00 ➝ $35.00	Equal Weight ➝ Equal Weight
MTG MGIC Investment	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.27 +0.6%	$23.00 ➝ $24.00	Equal Weight ➝ Equal Weight
MTZ MasTec	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$128.43 -0.9%	$123.00 ➝ $145.00	Overweight ➝ Overweight
MU Micron Technology	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.54 -0.4%	$145.00 ➝ $135.00	Overweight ➝ Overweight
NAPA Duckhorn Portfolio	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.95	$6.00 ➝ $11.00	Equal Weight ➝ Equal Weight
NAVI Navient	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.54 -1.8%	$10.00 ➝ $11.00	Underweight ➝ Underweight
NDAQ Nasdaq	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.19 +1.9%	$73.00 ➝ $79.00	Neutral ➝ Neutral
NDAQ Nasdaq	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.19 +1.9%	$88.00 ➝ $88.00	Outperform ➝ Outperform
NDAQ Nasdaq	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.19 +1.9%	$73.00 ➝ $80.00	Overweight ➝ Overweight
NET Cloudflare	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$81.78 +1.6%	$65.00	Underperform
NFLX Netflix	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$721.76 +2.8%	$750.00 ➝ $750.00	Overweight ➝ Overweight
NMIH NMI	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.19 +1.0%	$43.00 ➝ $48.00	Overweight ➝ Overweight
NOW ServiceNow	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$922.10 +1.8%	$900.00 ➝ $1,055.00	Buy ➝ Buy
NRG NRG Energy	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$93.56 -0.8%	$77.00 ➝ $118.00	Buy ➝ Buy
NTRS Northern Trust	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$91.06 +1.0%	$86.00 ➝ $92.00	Neutral ➝ Neutral
NVDA NVIDIA	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.89 +4.0%	$150.00 ➝ $150.00	Buy ➝ Buy
NVDA NVIDIA	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.89 +4.0%	$175.00 ➝ $175.00	Overweight ➝ Overweight
NVST Envista	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.20 -0.3%	$20.00	Equal Weight
NXPI NXP Semiconductors	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$234.96 +0.4%	$350.00 ➝ $270.00	Overweight ➝ Overweight
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now
OMF OneMain	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.77 -2.6%	$52.00 ➝ $46.00	Overweight ➝ Equal Weight
ON Onsemi	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$70.53 -0.8%	$95.00 ➝ $90.00	Overweight ➝ Overweight
OTIS Otis Worldwide	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.14 -2.8%		Outperform ➝ Peer Perform
OWL Blue Owl Capital	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.34 -1.8%	$21.00 ➝ $22.00	Outperform ➝ Outperform
PANW Palo Alto Networks	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$355.13 +5.1%	$376.00 ➝ $425.00	Buy ➝ Buy
PANW Palo Alto Networks	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$355.13 +5.1%	$410.00	Outperform
PD Precision Drilling	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$85.96 -3.4%	C$140.00 ➝ C$120.00	Buy
PDCO Patterson Companies	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.27 0.0%	$23.00 ➝ $22.00	In-Line ➝ In-Line
PEG Public Service Enterprise Group	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$91.00 +1.1%	$92.00 ➝ $95.00	Outperform ➝ Outperform
PEGA Pegasystems	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.77 +0.4%	$90.00 ➝ $90.00	Buy ➝ Buy
PEN Penumbra	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$195.09 +2.2%	$205.00 ➝ $222.00	Outperform ➝ Outperform
PENN PENN Entertainment	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Sigdahl Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.48 -0.5%	$30.00 ➝ $30.00	Buy ➝ Buy
PENN PENN Entertainment	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.48 -0.5%	$26.00 ➝ $26.00	Buy ➝ Buy
PFSI PennyMac Financial Services	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.16 +1.0%	$112.00 ➝ $125.00	Overweight ➝ Overweight
PJT PJT Partners	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$140.73 +2.7%	$110.00 ➝ $120.00	Sell ➝ Sell
PM Philip Morris International	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$118.75 -0.1%	$118.50 ➝ $132.00	Buy ➝ Buy
PRCT PROCEPT BioRobotics	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.00 +6.3%	$75.00 ➝ $75.00	Overweight ➝ Overweight
PSI Pason Systems	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$14.05 -3.2%	C$20.00 ➝ C$18.00	Buy
PSN Parsons	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$106.86 +0.7%	$99.00 ➝ $116.00	Overweight ➝ Overweight
PSX Phillips 66	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.31 -4.5%	$136.00 ➝ $144.00	Overweight ➝ Overweight
PSX Phillips 66	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$132.31 -4.5%	$138.00 ➝ $133.00	Equal Weight ➝ Equal Weight
PTCT PTC Therapeutics	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.77 +16.5%	$44.00 ➝ $44.00	Outperform ➝ Outperform
QCOM QUALCOMM	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$166.34 -0.4%	$215.00 ➝ $160.00	Neutral ➝ Neutral
QCOM QUALCOMM	Downgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$166.34 -0.4%		Overweight ➝ Sector Weight
RCUS Arcus Biosciences	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.46 +0.9%	$29.00	Overweight
RDN Radian Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.30 +0.6%	$32.00 ➝ $33.00	Equal Weight ➝ Equal Weight
REAL Real Matters	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$8.97 +3.3%	C$8.00 ➝ C$10.50	Outperform
RGA Reinsurance Group of America	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$213.59 +1.0%	$255.00 ➝ $250.00	Overweight ➝ Overweight
RGLS Regulus Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.55 -9.4%	$10.00 ➝ $10.00	Buy ➝ Buy
RIVN Rivian Automotive	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.47 -0.2%	$13.00 ➝ $11.00	Neutral ➝ Neutral
RKT Rocket Companies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.56 +0.3%	$10.00 ➝ $14.00	Underweight ➝ Underweight
RLI RLI	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$152.09 +0.1%	$162.00 ➝ $162.00	Sector Perform ➝ Sector Perform
SAGE Sage Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.43 -4.3%		Hold
SAVA Cassava Sciences	Upgraded by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Bernardino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.05 +2.5%	$116.00	Neutral ➝ Buy
SBUX Starbucks	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.21 +0.1%	$98.00 ➝ $99.00	Neutral ➝ Neutral
SEDG SolarEdge Technologies	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.56 -9.1%	$28.00 ➝ $23.00	Equal Weight ➝ Equal Weight
SEIC SEI Investments	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.97 +0.4%	$80.00 ➝ $81.00	Outperform ➝ Outperform
SGC Superior Group of Companies	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Cox Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.12 -0.1%	$24.00 ➝ $24.00	Buy ➝ Buy
SHEL Shell	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.27 -2.8%	$84.00 ➝ $88.00	Overweight ➝ Overweight
SIMO Silicon Motion Technology	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$60.19 0.0%	$90.00 ➝ $80.00	Buy ➝ Buy
SIRI Sirius XM	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.42 +1.3%	$65.00 ➝ $43.00	Buy ➝ Buy
SLM SLM	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.84 -0.4%	$23.00 ➝ $27.00	Overweight ➝ Overweight
SLN Silence Therapeutics	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.45 +4.5%	$49.00 ➝ $49.00	Overweight ➝ Overweight
SM SM Energy	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.16 -3.6%	$50.00 ➝ $50.00	Sector Perform ➝ Sector Perform
SM SM Energy	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.16 -3.6%	$50.00 ➝ $54.00	Overweight ➝ Overweight
SNCY Sun Country Airlines	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.57 +6.4%	$14.00	Peer Perform ➝ Outperform
SOC Sable Offshore	Initiated by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.78 -8.3%	$6.00	Sell
SOLV Solventum	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.11 +1.2%	$82.00	Buy
SPRY ARS Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Schimmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.88 +1.6%	$30.00 ➝ $30.00	Overweight ➝ Overweight
STZ Constellation Brands	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$241.13 -0.8%	$300.00 ➝ $270.00	Buy ➝ Hold
SVRA Savara	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.78 +1.1%	$10.00 ➝ $10.00	Buy ➝ Buy
SYNA Synaptics	Downgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.42 -4.8%		Overweight ➝ Sector Weight
TAP Molson Coors Beverage	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.98 -1.9%	$58.00 ➝ $56.00	Hold ➝ Hold
TCOM Trip.com Group	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.48 -10.1%		Buy ➝ Hold
TCW Trican Well Service	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.62 -4.7%	C$5.00 ➝ C$4.75	Hold
TDOC Teladoc Health	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.72 +0.8%	$8.00 ➝ $9.00	In-Line ➝ In-Line
TECK Teck Resources	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.59 -5.0%	$78.00 ➝ $79.00	Sector Outperform ➝ Sector Outperform
TECK.B Teck Resources	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$66.33 -4.8%	C$78.00 ➝ C$79.00	Outperform
TFII TFI International	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.85 +2.0%	$184.00 ➝ $181.00	Overweight
TFX Teleflex	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$234.95 +0.9%	$260.00 ➝ $275.00	Outperform ➝ Outperform
TRP TC Energy	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$60.95 -0.3%	C$66.00 ➝ C$60.00	Neutral
TRU TransUnion	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$106.15 +0.6%	$97.00 ➝ $118.00	Outperform ➝ Outperform
TSLA Tesla	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$244.50 +1.5%	$224.00 ➝ $236.00	Outperform ➝ Outperform
TSLA Tesla	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$244.50 +1.5%		Market Perform ➝ Market Perform
TTEK Tetra Tech	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.68 +3.5%	$49.00 ➝ $56.00	Overweight ➝ Overweight
TVTX Travere Therapeutics	Reiterated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.21 -0.3%	$20.00 ➝ $20.00	Outperform ➝ Outperform
TWLO Twilio	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.74 -1.2%	$110.00 ➝ $110.00	Market Outperform ➝ Market Outperform
TXN Texas Instruments	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$202.21 +0.5%	$210.00 ➝ $200.00	Neutral ➝ Neutral
UBSFY Ubisoft Entertainment	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.83 -4.1%		Sell ➝ Neutral
UFPI UFP Industries	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.00 +4.2%	$120.00 ➝ $155.00	Neutral ➝ Outperform
UNM Unum Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$60.40 -1.3%	$73.00 ➝ $72.00	Overweight ➝ Overweight
UUUU Energy Fuels	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.61 +3.9%	$10.50 ➝ $10.75	Buy ➝ Buy
UWMC UWM	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.33 -0.5%	$6.00 ➝ $8.00	Underweight ➝ Equal Weight
VEEV Veeva Systems	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$204.44 +1.3%	$286.00	Outperform
VINC Vincerx Pharma	Target Lowered by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.41 -41.6%	$4.00 ➝ $2.00	Outperform ➝ Outperform
VIRT Virtu Financial	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.08 +1.2%	$31.00 ➝ $35.00	Overweight ➝ Overweight
VOYA Voya Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$78.45 -1.0%	$84.00 ➝ $85.00	Overweight ➝ Overweight
VRTX Vertex Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$458.94 +2.3%	$480.00 ➝ $480.00	Overweight ➝ Overweight
VST Vistra	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Pourreza Subscribe to MarketBeat All Access for the recommendation accuracy rating	$127.94 -2.5%	$133.00 ➝ $177.00	Buy ➝ Buy
WAT Waters	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$358.78 +2.5%	$355.00 ➝ $415.00	Hold ➝ Buy
WAY Waystar	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.40 -0.7%	$27.00 ➝ $32.00	Outperform ➝ Outperform
WEN Wendy's	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.67 -0.5%	$19.00 ➝ $19.00	Equal Weight ➝ Equal Weight
WEN Wendy's	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.67 -0.5%	$18.00 ➝ $18.75	Neutral ➝ Neutral
WFC Wells Fargo & Company	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.28 +0.2%	$65.00	Peer Perform ➝ Outperform
WG John Wood Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 127 +1.3%	GBX 250	Buy
WMT Walmart	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.71 +0.8%	$82.00 ➝ $92.00	Outperform ➝ Outperform
WULF TeraWulf	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.91 -3.0%	$5.00 ➝ $5.00	Buy ➝ Buy
XOM Exxon Mobil	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$122.07 -2.6%	$120.00 ➝ $120.00	Sector Perform ➝ Sector Perform
XRAY DENTSPLY SIRONA	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.48	$29.00 ➝ $27.00	Outperform ➝ Outperform
ZBH Zimmer Biomet	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.77 -0.5%	$130.00 ➝ $120.00	Outperform ➝ Outperform
ZS Zscaler	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$176.93 +2.8%	$180.00	Neutral
ZYXI Zynex	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.74 -0.5%	$12.00 ➝ $11.00	Outperform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:11 PM ET.

(Ad)

The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

analyst ratings Headlines

Has Costco Stock Run Its Course for Now?
By Leo Miller | October 4, 2024
View Has Costco Stock Run Its Course for Now?
Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
By Leo Miller | October 1, 2024
View Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Get in on GE Vernova: Bank of America and Jefferies Are Bullish
By Leo Miller | September 26, 2024
View Get in on GE Vernova: Bank of America and Jefferies Are Bullish
PayPal Soars to New Heights: Why Analysts See More Upside
By Gabriel Osorio-Mazilli | September 25, 2024
View PayPal Soars to New Heights: Why Analysts See More Upside
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
By Leo Miller | September 20, 2024
View Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
e.l.f. Beauty: The High-Growth Stock You Shouldn't Ignore
By Leo Miller | September 18, 2024
View e.l.f. Beauty: The High-Growth Stock You Shouldn't Ignore
The Analyst Edge: How to Use Expert Opinions
By Jeffrey Neal Johnson | September 16, 2024
View The Analyst Edge: How to Use Expert Opinions